‘Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-CovidCNBC • 06/04/26
SPDR S&P Biotech ETF (XBI) Price Forecast: Long-Term Breakout Fuels Biotech StrengthFXEmpire • 05/08/26
Locking In A Quick Gain In This Biotech ETF Made Room For Better Swing Trades; Here's WhyInvestors Business Daily • 05/01/26
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now24/7 Wall Street • 04/23/26
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 202624/7 Wall Street • 04/07/26
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.24/7 Wall Street • 04/03/26
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead24/7 Wall Street • 03/28/26
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI WaveZacks Investment Research • 03/16/26
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In FocusBenzinga • 12/23/25
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock24/7 Wall Street • 12/02/25
Why biotech and drug stocks are on the mend even though the rest of the market is hurtingMarket Watch • 11/18/25